MRNA

Moderna, Inc.$70.03+0.47% 1D· price as of Jun 30, 8:32 PM

Universe

+154.28% over 1Y

Compare:MRNA

Mkt Cap

$27.8B

P/E

—

Fwd P/E

—

PEG

—

P/B

3.8×

P/S

12.5×

EV/EBITDA

—

Beta

1.03

Div Yield

0.0%

Payout

0.0%

ROE

-36.6%

Net Margin

-143.6%

Short % Flt

15.9%

Inst. Own

78.9%

52-wk low $22.28$70.0352-wk high $73.28

+214.3% above low-4.4% from high

Seasonality — avg monthly return

Strongest Jul 13.9% · weakest Aug -14.1%

Jan

+12.7

Feb

-8.3

Mar

+1.6

Apr

-0.7

May

+5.4

Jun

+9.2

Jul

+13.9

Aug

-14.1

Sep

-4.7

Oct

-4.6

Nov

-0.7

Dec

+2.4

Average month-over-month return per calendar month over the available history (~5 yrs); hover for the share of positive months. Past seasonality isn't predictive.

Ask AI about Moderna, Inc.

Gemini · web search

Searches the live web for current news & events plus this company's financials — and you can keep asking follow-up questions.

MRNA — recent news

Loading headlines…

Quality scorecard

vs Biotechnology · 8 peers · percentile rank

12 / 100

Weak

ROIC-25.6%

ROE-32.6%

Gross margin54.8%

Operating margin-159.9%

FCF yield-7.8%

Net debt / EBITDA0.5×

Percentile vs 8 Biotechnology peers — higher = better (leverage inverted: less debt ranks higher). The faint tick is the peer median; the score is the average percentile. Annual fundamentals.